Gilead Sciences announced that the FDA has granted Breakthrough Therapy Designation to breast cancer drug Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with extensive-stage ...

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on December 11.Pick the ...

GSK PLC GSK shares inched up 0.04% to £13.34 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.05% to 8,199.11. Supported ...

Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...

Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and Robert F. Kennedy Jr. as the possible HHS lead.

As 2024 draws to a close, we explore five stocks to buy for a new year that promises opportunity alongside uncertainty ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...

智通财经APP获悉，高盛发布研究报告称，翰森制药 (03692)12月18日宣布以1.12亿美元首付款及19亿美元里程碑付款及基于产品销售的特许权使用费，与默沙东订立全球独家许可协议-即口服GLP-1小分子药物HS-10535的全球销售权。高盛认为，翰森制药可在内地、港澳共同推广或单独商业化该产品。高盛予翰森制药“买入”及目标价20.97港元。

Telefon AB L.M. Ericsson Series A 1.67% kr299.55B ...

But, increased costs became a drag on net income in 2023 as firms invested in technology and infrastructure. Further ...

The low-risk approach by the drug giant is a sign of the extent of Eli Lilly and Novo Nordisk’s dominance in the weight-loss market.